Skip to content

Proton pump inhibitors and Clostridium difficile infection

Published: October 18, 2026Updated: October 18, 2026

Baron SW, Ma AS, Britt N

BMJ · 2018

This meta-analysis evaluates the intervention under study in relation to the primary clinical outcome. Includes 2,969,490 participants. Evidence level: IIa.

Quick summary

Evidence-Based Research: Ppi Clostridium Difficile Infection

Medically reviewed by WellAlly Editorial TeamLast reviewed October 18, 2026Editorial policy

Key facts at a glance

DOI
10.1136/bmj.l5317
PMID
30521587
Journal
BMJ
Year
2018
Study type
meta-analysis
Evidence level
IIa
Sample size
2969490
Intervention
PPI使用
Primary outcome
艰难梭菌感染发生率
Open access
false

Study Overview

This meta-analysis enrolled 2,969,490 participants and examined the primary clinical outcome.

Key Findings

Results regarding the primary clinical outcome are presented.

Clinical Conclusions

See original publication for detailed findings. Evidence level: IIa.

Abstract

"This meta-analysis enrolled 2,969,490 participants, investigating the effects of PPI使用 on 艰难梭菌感染发生率.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy

More meta analysis studies

View all